Contact us in British Columbia and Yukon


Crohn’s and colitis are much more manageable when we share our experiences with each other. Education events, chapter meetings, and fundraising activities are great opportunities to meet people who are living with IBD, their families and friends, and to learn of local resources and health professionals to support you and your family.

Leadership Giving Officer, Western Canada
Susan Hampton

604-314-1151

Coordinator, Development and Community Engagement, BC/Yukon
Teri McGeachie

250-213-7761
1-800-513-8202

Coordinator, Development & Community Engagement, Southwest BC
Mishal Tahir

778-879-3473
1-800-513-8202

young woman sitting on couch using tablet

Canada Wide Peer Connect Event

Ready to connect with those who understand the challenges of Crohn’s disease, ulcerative colitis, and other forms of inflammatory bowel disease (IBD)?   Join our upcoming Peer Connect ...

 • 
Virtual
 • 
Mom, dad, son and daughter outside enjoying the day

Caregiver Group Peer Support Event

Ready to connect with those who understand the challenges of being a caregiver to someone with Crohn’s disease, ulcerative colitis, and other forms of inflammatory bowel disease (IBD)?   ...

 • 
Virtual
 • 
Remember to bookmark this page.

British Columbia & Yukon Office

PO Box 47147 City Square
Vancouver, BC V5Z 4L6

bc@crohnsandcolitis.ca 1-800-513-8202

Search by Postal Code

News

The Canadian Inflammatory Bowel Disease Research Consortium awards first $1M Pioneer Grant from Takeda Canada

The Canadian Inflammatory Bowel Disease Research Consortium awards first $1M Pioneer Grant from Takeda Canada

Crohn’s and Colitis Canada and Pfizer Canada Announce 2022 Women in IBD Award Recipients

Crohn’s and Colitis Canada and Pfizer Canada Announce 2022 Women in IBD Award Recipients

Health Canada has approved SKYRIZI® (risankizumab) an intravenous and subcutaneous medication treatment for adults with moderately to severely active Crohn's Disease

Health Canada has approved SKYRIZI® (risankizumab) an intravenous and subcutaneous medication treatment for adults with moderately to severely active Crohn's Disease

 6 7 8 9 10 11 12 13 14 15